This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2005 Dec;128(Pt 12):3000-11.

doi: 10.1093/brain/awh666.

Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*

Daniela Berg, Katherine J Schweitzer, Petra Leitner, Alexander Zimprich, Peter Lichtner, Petra Belcredi, Theresa Brüssel, Claudia Schulte, Sylvia Maass, Thomas Nägele, Zbigniew K Wszolek, Thomas Gasser

PMID: 16251215
DOI: 10.1093/brain/awh666

Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*

Daniela Berg et al. Brain. 2005 Dec.

. 2005 Dec;128(Pt 12):3000-11.

doi: 10.1093/brain/awh666.

Authors

Daniela Berg, Katherine J Schweitzer, Petra Leitner, Alexander Zimprich, Peter Lichtner, Petra Belcredi, Theresa Brüssel, Claudia Schulte, Sylvia Maass, Thomas Nägele, Zbigniew K Wszolek, Thomas Gasser

PMID: 16251215
DOI: 10.1093/brain/awh666

No abstract available

PubMed Disclaimer

Comment in

Genetics of Parkinson's disease: LRRK2 on the rise.
Brice A. Brice A. Brain. 2005 Dec;128(Pt 12):2760-2. doi: 10.1093/brain/awh676. Brain. 2005. PMID: 16311269 No abstract available.

Similar articles

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.
Khan NL, Jain S, Lynch JM, Pavese N, Abou-Sleiman P, Holton JL, Healy DG, Gilks WP, Sweeney MG, Ganguly M, Gibbons V, Gandhi S, Vaughan J, Eunson LH, Katzenschlager R, Gayton J, Lennox G, Revesz T, Nicholl D, Bhatia KP, Quinn N, Brooks D, Lees AJ, Davis MB, Piccini P, Singleton AB, Wood NW. Khan NL, et al. Brain. 2005 Dec;128(Pt 12):2786-96. doi: 10.1093/brain/awh667. Epub 2005 Nov 4. Brain. 2005. PMID: 16272164
Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
Zhang L, Quadri M, Guedes LC, Coelho M, Valadas A, Mestre T, Lobo PP, Rosa MM, Simons E, Oostra BA, Ferreira JJ, Bonifati V. Zhang L, et al. Parkinsonism Relat Disord. 2013 Oct;19(10):897-900. doi: 10.1016/j.parkreldis.2013.05.003. Epub 2013 May 28. Parkinsonism Relat Disord. 2013. PMID: 23726462
LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson's disease.
Civitelli D, Tarantino P, Nicoletti G, Cirò Candiano IC, Annesi F, De Marco EV, Carrideo S, Rocca FE, Condino F, Spadafora P, Pugliese P, D'Asero S, Morelli M, Paglionico S, Annesi G, Quattrone A. Civitelli D, et al. Clin Genet. 2007 Apr;71(4):367-70. doi: 10.1111/j.1399-0004.2007.00771.x. Clin Genet. 2007. PMID: 17470139 No abstract available.
Clinical and pathologic features of families with LRRK2-associated Parkinson's disease.
Whaley NR, Uitti RJ, Dickson DW, Farrer MJ, Wszolek ZK. Whaley NR, et al. J Neural Transm Suppl. 2006;(70):221-9. doi: 10.1007/978-3-211-45295-0_34. J Neural Transm Suppl. 2006. PMID: 17017533 Review.
A trojan horse for Parkinson's disease.
Hu Y, Tong Y. Hu Y, et al. Sci Signal. 2010 Apr 6;3(116):pe13. doi: 10.1126/scisignal.3116pe13. Sci Signal. 2010. PMID: 20371768 Review.

See all similar articles

Cited by

Parkinson's disease: leucine-rich repeat kinase 2 and autophagy, intimate enemies.
Bravo-San Pedro JM, Gómez-Sánchez R, Pizarro-Estrella E, Niso-Santano M, González-Polo RA, Fuentes Rodríguez JM. Bravo-San Pedro JM, et al. Parkinsons Dis. 2012;2012:151039. doi: 10.1155/2012/151039. Epub 2012 Aug 30. Parkinsons Dis. 2012. PMID: 22970411 Free PMC article.
Theoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's Disease.
Qudrat A, Unni N. Qudrat A, et al. Yale J Biol Med. 2016 Jun 27;89(2):215-25. eCollection 2016 Jun. Yale J Biol Med. 2016. PMID: 27354847 Free PMC article. Review.
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers.
Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D, Valldeoriola F, Compta Y, Fernández-Santiago R, Fernández M, Bayés A, Calopa M, Casquero P, de Fàbregues O, Jaumà S, Puente V, Salamero M, José Martí M, Santamaría J, Tolosa E. Pont-Sunyer C, et al. PLoS One. 2015 Jul 15;10(7):e0132368. doi: 10.1371/journal.pone.0132368. eCollection 2015. PLoS One. 2015. PMID: 26177462 Free PMC article.
Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.
Burbulla LF, Schelling C, Kato H, Rapaport D, Woitalla D, Schiesling C, Schulte C, Sharma M, Illig T, Bauer P, Jung S, Nordheim A, Schöls L, Riess O, Krüger R. Burbulla LF, et al. Hum Mol Genet. 2010 Nov 15;19(22):4437-52. doi: 10.1093/hmg/ddq370. Epub 2010 Sep 2. Hum Mol Genet. 2010. PMID: 20817635 Free PMC article.
Recent Developments in LRRK2-Targeted Therapy for Parkinson's Disease.
Zhao Y, Dzamko N. Zhao Y, et al. Drugs. 2019 Jul;79(10):1037-1051. doi: 10.1007/s40265-019-01139-4. Drugs. 2019. PMID: 31161537 Review.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information
Molecular Biology Databases
- GlyGen glycoinformatics resource